Delivery Order SPE2DB22D1202-SPE2DB25FVCQ3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,557.45 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 26, 2025, with completion scheduled for August 27, 2025. This is a firm fixed price contract with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency Medical Supply Chain awarded a $14,224.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. The contract, which is a child order under a larger vehicle, has an ultimate completion date of August 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order valued at $6,139.84 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,394.50 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 5 mg/0.5 ml pens (0.5 ml units), with an ultimate completion date of August 18, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on open competition. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $65,338 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. This competitively awarded contract, which carries a completion date of September 24, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with...
- The Defense Logistics Agency awarded a $14,518.84 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on July 15, 2025, with completion scheduled for July 16, 2025. This competitive award carries firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract represents a firm fixed price delivery order with a completion date of June 23, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order is...
- The Defense Logistics Agency awarded a $11,312.79 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. The contract, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,379.96 delivery order on July 25, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 5 mg/0.5 mL pens valued at $3,050.32 with a completion date of August 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVCQ3Delivery Order
The Defense Logistics Agency awarded a $23,669.39 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed price, competitive award with no set-aside designation, with an ultimate completion date of June 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems. The Zepbound procurement supports DLA's medical supply chain requirements for weight management and diabetes treatment medications. AmerisourceBergen's federal contract portfolio demonstrates consistent competitively awarded performance across multiple therapeutic domains, with delivery orders typically structured as firm fixed price agreements, enabling the company to fulfill diverse federal medical supply needs ranging from routine pharmaceutical commodities to specialized healthcare products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.7k | 6/18/25 |